National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)s

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

23 Protocols (14 Active Accrual of new subjects, 9 Follow-up of previously enrolled subjects)

 000894-AR:

Natural History of Inflammatory Muscle Diseases

 000827-AR:

Natural History and Pathogenesis of Alopecia in Children and Adults

 000682-AR:

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients with Systemic Lupus Erythematosus

 000207-AR:

The Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases; An Observational Prospective Study

 18-AR-0081:

Investigation of the Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease and Related Inflammatory Conditions

 15-AR-0165:

Study of the Natural History, Pathogenesis and Outcome of Melorheostosis - a Rare Osteosclerotic Disease

 15-AR-0144:

Studies of Dermatologic Diseases-Biospecimen Acquisition Protocol

 14-AR-0200:

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

 12-AR-0159:

Effects of Treatments on the Microbiome in Healthy Volunteers and Patients with Atopic Dermatitis

 11-AR-0223:

Studies on the Natural History and Pathogenesis of Spondyloarthritis

 03-AR-0173:

Studies of Natural History, Pathogenesis, and Outcomes in Autoimmune and Inflammatory Diseases Including Juvenile Dermatomyositis

 01-AR-0227:

Studies of the Natural History of Rheumatic Disease in Minority Communities

 96-AR-0102:

Evaluation and Treatment of Subjects with Dermatologic Diseases

 94-AR-0066:

Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE)

 001700-AR:

A Randomized, Double-Blind, Placebo-Controlled, Phase Ib Study to Evaluate the Safety, Tolerability, And Pharmacokinetics of Gusacitinib in Subjects with Systemic Lupus Erythematosus (SLE)

 20-AR-0032:

Genomic Effects of Glucocorticoids in Patients with Systemic Lupus Erythematosus

 15-AR-0060:

The Role of PPAR-gamma Agonists in immunomodulation and Vascular Prevention in SLE (PPAR-SLE)

 13-AR-0056:

Stopping Tumor Necrosis Factor-Alpha Inhibitors in Rheumatoid Arthritis

 12-AR-8001:

Compassionate Use Treatment Protocol I4V-MC-JAGA; Treatment of Autoinflammatory Syndromes Expected to Benefit from JAK Inhibition

 06-AR-0198:

A Pilot Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity

 04-AR-0205:

Progression of Spinal Fusion in Ankylosing Spondylitis

 03-AR-0131:

Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study

 96-AR-0097:

The Acquisition of Blood and Skin Samples from Patient Volunteers to Support Research Activities on Dermatologic and Other Diseases